Cheryl Guttman Krader
According to Jeffrey Heier, MD, RGX-314 administered by subretinal injection was well tolerated. In addition, it was associated with dose-dependent increase in ocular protein expression and evidence of clinical benefit.
Nieraj Jain, MD, describes the investigations that led to the recent identification of this drug-related retinal toxicity and described the clinical features that support its diagnosis.
Speakers at AAO 2019 event describe journey leading to approval of the first gene therapy for a genetic disease.
Study shows routine use may improve patient management, guide procedure planning
Secondary outcome measures provide signals of efficacy
Researchers find that targeted subretinal delivery of stem cell derived RPE to geographic atrophy is feasible
Though anterior uveitis is associated with myriad conditions, a relatively short list of disorders accounts for the vast majority of cases.
Inhibition plays role in autoimmune-based inflammation; has unique mechanism of action
FA implant effective in lowering recurrence rates through available 6, 12 months of follow-up